Table 4 Site specific 5-year survival when compared to treatment strategy
From: Epidemiology and outcomes of gastrointestinal mucosal melanomas: a national database analysis
Primary Site | Total N | One year Survival (in %) | 5-year O.S. (in %) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
C | CRT | NT | R | S | SC | SCRT | SRT | |||
N | 46 | 30 | 286 | 59 | 487 | 82 | 33 | 80 | ||
p-value based onsite specific at 1 year | 0.034 | 0.411 | 0.028 | 0.152 | 0.00 | 0.966 | 0.006 | 0.271 | ||
ANAL CANAL | 325 | 48.0 | 18.5 | 25 | 21.3 | 50 | 45.5 | 11.5 | 23.7 | 32.6 |
ESOPHAGUS | 62 | 32.3 | 0 | 0 | 8.5 | 27.7 | 11.6 | 0 | ||
GALLBLADDER | 19 | 68.4 | 40 | 61.5 | ||||||
LARGE BOWEL | 29 | 69.0 | 0 | 34.3 | 70 | 100 | ||||
LIVER | 1 | 100.0 | ||||||||
OTHER | 6 | 16.7 | 0 | 25 | 0 | |||||
OVERLAPPING LESION OF RECTUM AND ANAL CANAL | 214 | 49.1 | 31.3 | 0 | 40 | 25 | 33.6 | 34 | 14.3 | 22.2 |
PANCREAS | 4 | 25.0 | 33.3 | 0 | ||||||
RECTUM | 352 | 41.8 | 0 | 11.2 | 26.4 | 0 | 31.3 | 18.5 | 44.4 | 34 |
SMALL BOWEL | 52 | 51.9 | 50 | 0 | 0 | 54 | 41.7 | 50 | 0 | |
STOMACH | 39 | 43.6 | 0 | 18.6 | 0 | 32.1 | 50 | |||